Gene: SDHAF4
Official Full Name: succinate dehydrogenase complex assembly factor 4provided by HGNC
Gene Summary: Predicted to enable enzyme activator activity. Involved in cellular respiration and mitochondrial respiratory chain complex II assembly. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26403 | SDHAF4 Knockout cell line (HeLa) | Human | SDHAF4 | 1:3~1:6 | Negative | Online Inquiry |
KO26404 | SDHAF4 Knockout cell line (HCT 116) | Human | SDHAF4 | 1:2~1:4 | Negative | Online Inquiry |
KO26405 | SDHAF4 Knockout cell line (HEK293) | Human | SDHAF4 | 1:3~1:6 | Negative | Online Inquiry |
KO26406 | SDHAF4 Knockout cell line (A549) | Human | SDHAF4 | 1:3~1:4 | Negative | Online Inquiry |
SDHAF4 Gene Knockout Cell Lines are customized cellular models engineered to specifically disrupt the function of the SDHAF4 gene, which is implicated in various metabolic pathways and has been linked to cellular respiration processes. This gene's role is primarily related to the assembly and function of the succinate dehydrogenase (SDH) complex, critical for the mitochondrial electron transport chain. By utilizing CRISPR/Cas9 technology, these cell lines allow researchers to study the consequences of SDHAF4 knockout and understand its involvement in metabolic dysregulation and related diseases.
These cell lines operate by providing a platform for examining the metabolic changes that arise from SDHAF4 deficiency, thereby elucidating its role in cellular energy production. Researchers can utilize these knockout models to investigate the downstream effects on mitochondrial function, the Krebs cycle, and overall cellular homeostasis. Their importance is underscored in research areas such as cancer biology, where mitochondrial dysfunction is heavily implicated, and in the development of therapeutic strategies targeting metabolic disorders.
In comparison to conventional knockout methods, the SDHAF4 Gene Knockout Cell Lines provide enhanced precision and efficiency. They come pre-validated, saving researchers the time and resources typically spent on developing and confirming knockout models. Additionally, the ability to leverage these cell lines in high-throughput screening processes positions them as an invaluable asset for drug discovery and functional genomics.
For scientists and clinicians focused on unraveling the complexities of mitochondrial disease and metabolic pathways, the SDHAF4 Gene Knockout Cell Lines offer a comprehensive and reliable tool for driving forward innovative research. Our company prides itself on delivering high-quality biological products, backed by extensive expertise in genetic engineering, ensuring that our offerings continuously meet the evolving needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.